Stone Ridge Asset Management LLC acquired a new stake in American Renal Associates Holdings Inc (NYSE:ARA) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 18,662 shares of the company’s stock, valued at approximately $325,000. Stone Ridge Asset Management LLC owned 0.06% of American Renal Associates as of its most recent SEC filing.
A number of other hedge funds and other institutional investors also recently bought and sold shares of ARA. Dimensional Fund Advisors LP acquired a new stake in American Renal Associates in the second quarter valued at $230,000. State Street Corp increased its holdings in American Renal Associates by 5.2% in the second quarter. State Street Corp now owns 146,039 shares of the company’s stock valued at $2,709,000 after purchasing an additional 7,244 shares during the period. The Manufacturers Life Insurance Company increased its holdings in American Renal Associates by 19.7% in the second quarter. The Manufacturers Life Insurance Company now owns 8,778 shares of the company’s stock valued at $162,000 after purchasing an additional 1,443 shares during the period. Citadel Advisors LLC acquired a new stake in American Renal Associates in the third quarter valued at $200,000. Finally, Schwab Charles Investment Management Inc. increased its holdings in American Renal Associates by 67.8% in the third quarter. Schwab Charles Investment Management Inc. now owns 65,661 shares of the company’s stock valued at $983,000 after purchasing an additional 26,529 shares during the period. Institutional investors and hedge funds own 91.64% of the company’s stock.
Shares of American Renal Associates stock opened at $18.85 on Monday. The company has a debt-to-equity ratio of 4.28, a current ratio of 1.20 and a quick ratio of 1.17. American Renal Associates Holdings Inc has a 1-year low of $9.91 and a 1-year high of $24.07. The stock has a market cap of $593.03, a price-to-earnings ratio of 31.95, a price-to-earnings-growth ratio of 1.30 and a beta of 1.92.
ARA has been the subject of a number of recent research reports. Zacks Investment Research downgraded American Renal Associates from a “hold” rating to a “sell” rating in a report on Tuesday, January 23rd. SunTrust Banks set a $20.00 price objective on American Renal Associates and gave the company a “buy” rating in a report on Thursday, December 21st. Finally, Leerink Swann downgraded American Renal Associates from an “outperform” rating to a “market perform” rating and increased their price objective for the company from $17.00 to $27.00 in a report on Thursday, March 8th.
ILLEGAL ACTIVITY NOTICE: “Stone Ridge Asset Management LLC Invests $325,000 in American Renal Associates Holdings Inc (ARA) Stock” was reported by WKRB News and is the property of of WKRB News. If you are accessing this news story on another website, it was illegally stolen and republished in violation of US & international trademark & copyright laws. The legal version of this news story can be accessed at https://www.wkrb13.com/2018/04/02/stone-ridge-asset-management-llc-invests-325000-in-american-renal-associates-holdings-inc-ara-stock.html.
American Renal Associates Company Profile
American Renal Associates Holdings, Inc is a dialysis service provider in the United States focused on joint venture (JV) partnerships with physicians. As of December 31, 2016, the Company owned and operated 214 dialysis clinics in partnership with 379 nephrologist partners treating over 14,000 patients in 25 states and the District of Columbia.
Want to see what other hedge funds are holding ARA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for American Renal Associates Holdings Inc (NYSE:ARA).
Receive News & Ratings for American Renal Associates Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Renal Associates and related companies with MarketBeat.com's FREE daily email newsletter.